Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.
Based in Ontario, Brookdale Treeland Nurseries is a leading full-service supplier of live garden plants and decorative holiday greenery in Canada. The company mainly serves wholesale retailers and landscape contractors, municipalities and golf courses throughout Canada and the US. Spring product mix includes trees, flowering shrubs, evergreens, broadleaf evergreens, vines, fruits and perennials. Holiday product mix includes outdoor arrangements, wreaths, bouquets and swags.
Founded in 2008, Rouge River Capital is a diversified investment holding company made up of over 20 strong operating businesses. These businesses span the trucking, manufacturing, dealership, real estate and leasing industries. Rouge River Capital partners with the management teams to drive sustained long-term value.
Oaklins’ team in Canada, supported by the team in the Netherlands, acted as the sell-side M&A advisor to Brookdale Treeland Nurseries in this transaction. Brookdale benefited from Oaklins’ expertise and knowledge in the horticulture space.
Jeff Olsen
Owner, Brookdale Treeland Nurseries
Talk to the deal team
Related deals
ABZ Seeds has been acquired by Planasa
ABZ Seeds, a renowned breeder of seed-propagated F1 hybrid strawberry varieties, has been acquired by Planasa, a global leader in breeding next-generation berry varieties, including blueberries, blackberries, raspberries and strawberries.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more